Retrieve available abstracts of 70 articles: HTML format
Single Articles
July 2025
Correction: pancreatic STAT5 activation promotes KrasG12D-induced and
inflammation-induced acinar-to-ductal metaplasia and pancreatic cancer.
Gut. 2025 Jul 2:gutjnl-2024-332225corr1. doi: 10.1136/gutjnl-2024-332225. PubMed
June 2025
HARLE A, Kleger A Early metabolic fate commitment in pancreatic neoplastic precursors.
Gut. 2025 Jun 4:gutjnl-2025-335439. doi: 10.1136/gutjnl-2025-335439. PubMed
YANG J, Yu X, Xiao M, Xu H, et al Histone lactylation-driven feedback loop modulates cholesterol-linked
immunosuppression in pancreatic cancer.
Gut. 2025 Jun 4:gutjnl-2024-334361. doi: 10.1136/gutjnl-2024-334361. PubMedAbstract available
April 2025
HUANG L, Feng Z, Yang W, Zhu Y, et al Parecoxib sequential with imrecoxib for occurrence and remission of severe acute
pancreatitis: a multicentre, double-blind, randomised, placebo-controlled trial.
Gut. 2025 Apr 29:gutjnl-2024-334038. doi: 10.1136/gutjnl-2024-334038. PubMedAbstract available
CHEN Y, Ballaro R, Sans M, Thege FI, et al Long-chain sulfatide enrichment is an actionable metabolic vulnerability in
intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancers.
Gut. 2025 Apr 23:gutjnl-2025-335220. doi: 10.1136/gutjnl-2025-335220. PubMedAbstract available
BODAS C, Felipe I, Chanez B, Lafarga M, et al A Common CTRB misfolding variant associated with pancreatic cancer risk causes ER
stress and inflammation in mice.
Gut. 2025 Apr 19:gutjnl-2024-333406. doi: 10.1136/gutjnl-2024-333406. PubMedAbstract available
WU H, Gao SZ, Yin LD, Wang YH, et al Germline mutations and pancreatic cancer risk in chronic pancreatitis.
Gut. 2025 Apr 5:gutjnl-2024-334277. doi: 10.1136/gutjnl-2024-334277. PubMed
March 2025
PERRI G, Marchegiani G Introducing 'borderline observable' intraductal papillary mucinous neoplasms:
between pancreatic cancer risk and discontinuation of extended surveillance.
Gut. 2025 Mar 26:gutjnl-2025-334807. doi: 10.1136/gutjnl-2025-334807. PubMed
SUN X, Cai W, Li H, Gao C, et al Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer
metastasis via vasculogenic mimicry and paracrine signalling.
Gut. 2025 Mar 23:gutjnl-2024-333638. doi: 10.1136/gutjnl-2024-333638. PubMedAbstract available
COTE GA Rectal non-steroidal anti-inflammatory drugs and post-ERCP pancreatitis: it is
time for the next chapter in prophylaxis.
Gut. 2025 Mar 23:gutjnl-2025-334989. doi: 10.1136/gutjnl-2025-334989. PubMed
KANG X, Xia M, Wang J, Wang X, et al Rectal diclofenac versus indomethacin for prevention of post-ERCP pancreatitis
(DIPPP): a multicentre, double-blind, randomised, controlled trial.
Gut. 2025 Mar 20:gutjnl-2024-334466. doi: 10.1136/gutjnl-2024-334466. PubMedAbstract available
January 2025
EKSTROM TL, Rosok RM, Abdelrahman AM, Parassiadis C, et al Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release
to modulate classical subtype identity in pancreatic cancer.
Gut. 2025 Jan 30:gutjnl-2024-334374. doi: 10.1136/gutjnl-2024-334374. PubMedAbstract available
HAMADA T, Oyama H, Nevo D, Tange S, et al Risk factors for pancreatic cancer in individuals with intraductal papillary
mucinous neoplasms and no high-risk stigmata during up to 5 years of
surveillance: a prospective longitudinal cohort study.
Gut. 2025 Jan 27:gutjnl-2024-333259. doi: 10.1136/gutjnl-2024-333259. PubMedAbstract available
ZHANG S, Deng S, Liu J, Liu S, et al Targeting MXD1 sensitises pancreatic cancer to trametinib.
Gut. 2025 Jan 16:gutjnl-2024-333408. doi: 10.1136/gutjnl-2024-333408. PubMedAbstract available
RUSSELL SN, Demetriou C, Valenzano G, Evans A, et al Induction of macrophage efferocytosis in pancreatic cancer via PI3Kgamma inhibition
and radiotherapy promotes tumour control.
Gut. 2025 Jan 9:gutjnl-2024-333492. doi: 10.1136/gutjnl-2024-333492. PubMedAbstract available
TAN JT, Mao X, Cheng HM, Seto WK, et al Aspirin is associated with lower risk of pancreatic cancer and cancer-related
mortality in patients with diabetes mellitus.
Gut. 2025 Jan 2:gutjnl-2024-333329. doi: 10.1136/gutjnl-2024-333329. PubMedAbstract available
December 2024
MASSON E, Vedie AL, Maire F, Godet T, et al Frequency of de novo PRSS1 pathogenic variants in a French cohort of idiopathic
pancreatitis.
Gut. 2024 Dec 31:gutjnl-2024-333908. doi: 10.1136/gutjnl-2024-333908. PubMed
HOLLENBACH M, Heise C, Abou-Ali E, Gulla A, et al Endoscopic papillectomy versus surgical ampullectomy for adenomas and early
cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club
analysis.
Gut. 2024 Dec 12:gutjnl-2022-327996. doi: 10.1136/gutjnl-2022-327996. PubMedAbstract available
Correction: The Peptidoglycan Recognition Protein 1 confers immune evasive
properties on pancreatic cancer stem cells.
Gut. 2024;74:e11. PubMed
November 2024
XIAO M, Tang R, Pan H, Yang J, et al TPX2 serves as a novel target for expanding the utility of PARPi in pancreatic
cancer through conferring synthetic lethality.
Gut. 2024 Nov 5:gutjnl-2024-332782. doi: 10.1136/gutjnl-2024-332782. PubMedAbstract available
October 2024
ESPINET E, Natoli G Leveraging the tug-of-war with genomic retroelements to enhance immunotherapy of
pancreatic cancer.
Gut. 2024 Oct 22:gutjnl-2024-333702. doi: 10.1136/gutjnl-2024-333702. PubMed
ONNEKINK AM, Gorris M, Bekkali NL, Bos P, et al Endoscopic sphincterotomy to prevent post-ERCP pancreatitis after self-expandable
metal stent placement for distal malignant biliary obstruction (SPHINX): a
multicentre, randomised controlled trial.
Gut. 2024 Oct 10:gutjnl-2024-332695. doi: 10.1136/gutjnl-2024-332695. PubMedAbstract available
September 2024
SANDOR M, Scheers I, Masamune A, Witt H, et al AlphaMissense versus laboratory-based pathogenicity prediction of 13 novel
missense CPA1 variants from pancreatitis cases.
Gut. 2024 Sep 10:gutjnl-2024-333697. doi: 10.1136/gutjnl-2024-333697. PubMed
Correction: Macrophages direct cancer cells through a LOXL2-mediated metastatic
cascade in pancreatic ductal adenocarcinoma.
Gut. 2024;73:e21. PubMed
COTE GA, Elmunzer BJ, Nitchie H, Kwon RS, et al Sphincterotomy for biliary sphincter of Oddi disorder and idiopathic acute
recurrent pancreatitis: the RESPOnD longitudinal cohort.
Gut. 2024 Sep 7:gutjnl-2024-332686. doi: 10.1136/gutjnl-2024-332686. PubMedAbstract available
August 2024
TANG Y, Tang S, Yang W, Zhang Z, et al MED12 loss activates endogenous retroelements to sensitise immunotherapy in
pancreatic cancer.
Gut. 2024 Aug 31:gutjnl-2024-332350. doi: 10.1136/gutjnl-2024-332350. PubMedAbstract available
ZHOU T, Hou X, Yan J, Li L, et al CD64(+) fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs
efficacy against pancreatic cancer by reducing desmoplasia and enriching
stem-like CD8(+) T cells.
Gut. 2024 Aug 30:gutjnl-2024-332371. doi: 10.1136/gutjnl-2024-332371. PubMedAbstract available
July 2024
ZUO X, Wang L, Liu Y, Wang H, et al Dysregulated KLF4 expression plays a pivotal role in the pathogenesis of
pancreatic intraductal papillary mucinous neoplasms.
Gut. 2024 Jul 5:gutjnl-2024-332255. doi: 10.1136/gutjnl-2024-332255. PubMed
KAMAR N, Marion O, Abravanel F, Esposito L, et al Porcine-derived pancreatic enzyme replacement therapy: a cause of hepatitis E
virus transmission?
Gut. 2024 Jul 2:gutjnl-2024-332744. doi: 10.1136/gutjnl-2024-332744. PubMed
LIN Y, Pu S, Wang J, Wan Y, et al Pancreatic STAT5 activation promotes Kras(G12D)-induced and inflammation-induced
acinar-to-ductal metaplasia and pancreatic cancer.
Gut. 2024 Jul 1:gutjnl-2024-332225. doi: 10.1136/gutjnl-2024-332225. PubMedAbstract available
June 2024
SHEN F, Zhao H, Deng M, Tu M, et al Familial pancreatitis associated with a splice-site variant in CPA1.
Gut. 2024 Jun 18:gutjnl-2024-332845. doi: 10.1136/gutjnl-2024-332845. PubMed
ZHOU J, Liu K, Pan Q Porcine-derived pancreatic enzyme replacement therapy linking to chronic
hepatitis E: broad implications.
Gut. 2024 Jun 12:gutjnl-2024-332975. doi: 10.1136/gutjnl-2024-332975. PubMed
BRICHKINA A, Ems M, Suezov R, Singh R, et al DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer.
Gut. 2024 Jun 4:gutjnl-2023-331854. doi: 10.1136/gutjnl-2023-331854. PubMedAbstract available
May 2024
FRERICKS N, Kinast V, Steinmann E Potential risk of porcine-derived pancreatic enzyme medication for the
cross-species transmission of hepatitis E virus.
Gut. 2024 May 31:gutjnl-2024-332577. doi: 10.1136/gutjnl-2024-332577. PubMed
VOGT M, Dudvarski Stankovic N, Cruz Garcia Y, Hofstetter J, et al Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase
RUVBL1/2.
Gut. 2024 May 31:gutjnl-2023-331519. doi: 10.1136/gutjnl-2023-331519. PubMedAbstract available
BERKE G, Sahin-Toth M Intron-mediated enhancement of SPINK1 expression for pancreatitis therapy.
Gut. 2024 May 16:gutjnl-2024-332818. doi: 10.1136/gutjnl-2024-332818. PubMed
LOPEZ-GIL JC, Garcia-Silva S, Ruiz-Canas L, Navarro D, et al The Peptidoglycan Recognition Protein 1 confers immune evasive properties on
pancreatic cancer stem cells.
Gut. 2024 May 16:gutjnl-2023-330995. doi: 10.1136/gutjnl-2023-330995. PubMedAbstract available
April 2024
THORNTON CS, Waddell BJ, Congly SE, Svishchuk J, et al Porcine-derived pancreatic enzyme replacement therapy may be linked to chronic
hepatitis E virus infection in cystic fibrosis lung transplant recipients.
Gut. 2024 Apr 15:gutjnl-2023-330602. doi: 10.1136/gutjnl-2023-330602. PubMedAbstract available
Correction: Identification of c-FLIPL and c-FLIPS as critical regulators of death
receptor-induced apoptosis in pancreatic cancer cells.
Gut. 2024;73:e8. PubMed
March 2024
WANG YC, Mao XT, Sun C, Wang YH, et al Pancreas-directed AAV8-hSPINK1 gene therapy safely and effectively protects
against pancreatitis in mice.
Gut. 2024 Mar 29:gutjnl-2023-330788. doi: 10.1136/gutjnl-2023-330788. PubMedAbstract available
GUNJAN D, Mahapatra SJ, Garg PK Is acute necrotising pancreatitis a chronic disease?
Gut. 2024 Mar 26:gutjnl-2024-331915. doi: 10.1136/gutjnl-2024-331915. PubMed
AMMER-HERRMENAU C, Neesse A Response to: short-chain fatty acids in patients with severe acute pancreatitis:
friend or foe?
Gut. 2024 Mar 7:gutjnl-2024-332236. doi: 10.1136/gutjnl-2024-332236. PubMed
PUST MM, Rocha Castellanos DM, Rzasa K, Dame A, et al Absence of a pancreatic microbiome in intraductal papillary mucinous neoplasm.
Gut. 2024 Mar 1:gutjnl-2023-331012. doi: 10.1136/gutjnl-2023-331012. PubMedAbstract available
February 2024
VAN DEN BERG FF, Besselink MG, van Santvoort H Short-chain fatty acids in patients with severe acute pancreatitis: friend or
foe?
Gut. 2024 Feb 15:gutjnl-2024-332129. doi: 10.1136/gutjnl-2024-332129. PubMed
January 2024
HOLLEMANS RA, Timmerhuis HC, Besselink MG, Bouwense SAW, et al Long-term follow-up study of necrotising pancreatitis: interventions,
complications and quality of life.
Gut. 2024 Jan 24:gutjnl-2023-329735. doi: 10.1136/gutjnl-2023-329735. PubMedAbstract available
TONELLI C, Yordanov GN, Hao Y, Deschenes A, et al A mucus production programme promotes classical pancreatic ductal adenocarcinoma.
Gut. 2024 Jan 23:gutjnl-2023-329839. doi: 10.1136/gutjnl-2023-329839. PubMedAbstract available
SABA E, Farhat M, Daoud A, Khashan A, et al Oral bacteria accelerate pancreatic cancer development in mice.
Gut. 2024 Jan 17:gutjnl-2023-330941. doi: 10.1136/gutjnl-2023-330941. PubMedAbstract available
KWAN MC, Pitman MB, Fernandez-Del Castillo C, Zhang ML, et al Revisiting the performance of cyst fluid carcinoembryonic antigen as a diagnostic
marker for pancreatic mucinous cysts: a comprehensive 20-year institutional
review.
Gut. 2024 Jan 9:gutjnl-2023-331138. doi: 10.1136/gutjnl-2023-331138. PubMedAbstract available
December 2023
AMMER-HERRMENAU C, Antweiler KL, Asendorf T, Beyer G, et al Gut microbiota predicts severity and reveals novel metabolic signatures in acute
pancreatitis.
Gut. 2023 Dec 21:gutjnl-2023-330987. doi: 10.1136/gutjnl-2023-330987. PubMedAbstract available
BEN-AMI R, Wang QL, Zhang J, Supplee JG, et al Protein biomarkers and alternatively methylated cell-free DNA detect early stage
pancreatic cancer.
Gut. 2023 Dec 13:gutjnl-2023-331074. doi: 10.1136/gutjnl-2023-331074. PubMedAbstract available
HANNEMANN A, Mayerle J, Beyer G Response to: Correspondence on 'Definition of age-dependent reference values for
the diameter of the common bile duct and pancreatic duct on MRCP: still needed
further discussion' by Wang et al.
Gut. 2023 Dec 2:gutjnl-2023-331525. doi: 10.1136/gutjnl-2023-331525. PubMed
October 2023
SANDOR M, Sahin-Toth M Functional predictors of pathogenicity of missense CPA1 variants in chronic
pancreatitis.
Gut. 2023 Oct 19:gutjnl-2023-331105. doi: 10.1136/gutjnl-2023-331105. PubMed
WANG F, Peng L, Liu Y Definition of age-dependent reference values for the diameter of the common bile
duct and pancreatic duct on MRCP: still needed further discussion.
Gut. 2023 Oct 10:gutjnl-2023-331163. doi: 10.1136/gutjnl-2023-331163. PubMed
MICHL P, Roth L Female advantage in neoadjuvant pancreatic cancer therapy: is it down to
macrophages?
Gut. 2023 Oct 9:gutjnl-2023-330830. doi: 10.1136/gutjnl-2023-330830. PubMed
September 2023
VAN EIJCK CWF, Mustafa DAM, Vadgama D, de Miranda NFCC, et al Enhanced antitumour immunity following neoadjuvant chemoradiotherapy mediates a
favourable prognosis in women with resected pancreatic cancer.
Gut. 2023 Sep 14:gutjnl-2023-330480. doi: 10.1136/gutjnl-2023-330480. PubMedAbstract available
WU Y, Seufert I, Al-Shaheri FN, Kurilov R, et al DNA-methylation signature accurately differentiates pancreatic cancer from
chronic pancreatitis in tissue and plasma.
Gut. 2023 Sep 14:gutjnl-2023-330155. doi: 10.1136/gutjnl-2023-330155. PubMedAbstract available
KARSTENSEN JG, Novovic S, Schmidt PN Tailoring treatment to the circumstance: reasoning behind metal versus plastic
drainage of pancreatic collections - authors' reply.
Gut. 2023 Sep 12:gutjnl-2023-330948. doi: 10.1136/gutjnl-2023-330948. PubMed
August 2023
LIU X, Tang R, Xu J, Tan Z, et al CRIP1 fosters MDSC trafficking and resets tumour microenvironment via
facilitating NF-kappaB/p65 nuclear translocation in pancreatic ductal adenocarcinoma.
Gut. 2023 Aug 4:gutjnl-2022-329349. doi: 10.1136/gutjnl-2022-329349. PubMedAbstract available
July 2023
VANELLA G, Bronswijk M, Van der Merwe SW, Arcidiacono PG, et al Tailoring treatment to the circumstance: reasoning behind metal versus plastic
drainage of pancreatic collections.
Gut. 2023 Jul 31:gutjnl-2023-330442. doi: 10.1136/gutjnl-2023-330442. PubMed
June 2023
BLANCO-GOMEZ A, Jorgensen C FAK scaffolds immune escape in pancreatic cancer.
Gut. 2023 Jun 6:gutjnl-2023-330049. doi: 10.1136/gutjnl-2023-330049. PubMed
SAMANTA J, Dhar J Plastic is as good as metal: is the 'debris clearance' debate for walled-off
necrosis drainage finally over?
Gut. 2023;72:1223-1224. PubMed
May 2023
KINKER GS, Vitiello GAF, Diniz AB, Cabral-Piccin MP, et al Mature tertiary lymphoid structures are key niches of tumour-specific immune
responses in pancreatic ductal adenocarcinomas.
Gut. 2023 May 25:gutjnl-2022-328697. doi: 10.1136/gutjnl-2022-328697. PubMedAbstract available
April 2023
ZORNIAK M, Sirtl S, Beyer G, Mahajan UM, et al Consensus definition of sludge and microlithiasis as a possible cause of
pancreatitis.
Gut. 2023 Apr 18:gutjnl-2022-327955. doi: 10.1136/gutjnl-2022-327955. PubMedAbstract available
BANG JY, Jhala N, Seth A, Krall K, et al Standardisation of EUS-guided FNB technique for molecular profiling in pancreatic
cancer: results of a randomised trial.
Gut. 2023 Apr 11:gutjnl-2023-329495. doi: 10.1136/gutjnl-2023-329495. PubMed
RAPETTI-MAUSS R, Nigri J, Berenguier C, Finetti P, et al SK2 channels set a signalling hub bolstering CAF-triggered tumourigenic processes
in pancreatic cancer.
Gut. 2023;72:722-735. PubMedAbstract available
March 2023
CANEL M, Slawinska AD, Lonergan DW, Kallor AA, et al FAK suppresses antigen processing and presentation to promote immune evasion in
pancreatic cancer.
Gut. 2023 Mar 28:gutjnl-2022-327927. doi: 10.1136/gutjnl-2022-327927. PubMedAbstract available
HAMDAN FH, Abdelrahman AM, Kutschat AP, Wang X, et al Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and
adaptive resistance in pancreatic cancer.
Gut. 2023 Mar 8:gutjnl-2022-328154. doi: 10.1136/gutjnl-2022-328154. PubMedAbstract available
February 2023
HALLENSLEBEN ND, Stassen PMC, Schepers NJ, Besselink MG, et al Patient selection for urgent endoscopic retrograde cholangio-pancreatography by
endoscopic ultrasound in predicted severe acute biliary pancreatitis (APEC-2): a
multicentre prospective study.
Gut. 2023 Feb 27:gutjnl-2022-328258. doi: 10.1136/gutjnl-2022-328258. PubMedAbstract available
LIU J, Bai W, Zhou T, Xie Y, et al SDCBP promotes pancreatic cancer progression by preventing YAP1 from
beta-TrCP-mediated proteasomal degradation.
Gut. 2023 Feb 24:gutjnl-2022-327492. doi: 10.1136/gutjnl-2022-327492. PubMedAbstract available
BEYER G, Kasprowicz F, Hannemann A, Aghdassi A, et al Definition of age-dependent reference values for the diameter of the common bile
duct and pancreatic duct on MRCP: a population-based, cross-sectional cohort
study.
Gut. 2023 Feb 24:gutjnl-2021-326106. doi: 10.1136/gutjnl-2021-326106. PubMedAbstract available